News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025
News Conference News ESC 2023 ESC Focused Update on HF Synthesizes New Trial Data for Practical Use L.A. McKeown September 01, 2023
Presentation ESC 2023 The HEART-FID Trial: Efficacy and Safety of Ferric Carboxymaltose as Treatment for Heart Failure with Iron Deficiency Presenter: Robert Mentz August 28, 2023
News Conference News ESC 2023 IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role Shelley Wood August 26, 2023
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2023 Shelley Wood July 03, 2023
News Daily News FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose Shelley Wood June 05, 2023
News Conference News AHA 2022 IRONMAN Misses but Lends Support to IV Iron Repletion in HF Shelley Wood November 05, 2022
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Conference News ESC Heart Failure 2021 IRON-CRT: IV Iron Boosts LVEF, Cardiac Contractility in Deficient HF Patients Shelley Wood June 30, 2021
News Conference News AHA 2020 AFFIRM-AHF: IV Iron Supplementation Linked to Fewer Repeat Hospitalizations for HF L.A. McKeown November 13, 2020
Presentation AHA 2016 Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF) Presenter: Dirk J. van Veldhuisen November 16, 2016
News Conference News AHA 2016 Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients Michael O'Riordan November 16, 2016